MR antagonist (Hunan Nucien Pharmaceutical)

N/A

Report date: 2025/03/20 15:01:34
NME

Base Information

Drug NameMR antagonist (Hunan Nucien Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMineralocorticoid receptor antagonists
TargetsMineralocorticoid receptor
Therapy Area/IndicationsHypertensionHeart FailureDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHunan Nucien Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHunan Nucien Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertensionHeart FailureDiabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A